ivacaftor
Showing 26 - 46 of 46
COPD Trial in Birmingham (Ivacaftor, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Ivacaftor
- Placebo
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 5, 2017
Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation Trial in Worldwide (Lumacaftor Plus Ivacaftor
Completed
- Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation
- Lumacaftor Plus Ivacaftor Combination
- Ivacaftor
-
Birmingham, Alabama
- +166 more
Apr 3, 2017
Cystic Fibrosis Trial in Melbourne (ivacaftor, )
Unknown status
- Cystic Fibrosis
- ivacaftor
- placebo
-
Melbourne, Victoria, AustraliaThe Alfred
Jul 21, 2016
Cystic Fibrosis, Homozygous for the F508del CFTR Mutation Trial in Worldwide (Placebo, Lumacaftor Plus Ivacaftor Combination,
Completed
- Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
- Placebo
- +2 more
-
Oakland, California
- +81 more
Aug 15, 2016
Cystic Fibrosis Trial in Denver (Ivacaftor, Placebo-matched-to-ivacaftor tablet)
Completed
- Cystic Fibrosis
- Ivacaftor
- Placebo-matched-to-ivacaftor tablet
-
Denver, Colorado(unnamed)
Apr 30, 2015
Cystic Fibrosis, Homozygous for the F508del CFTR Mutation Trial in Worldwide (Lumacaftor Plus Ivacaftor Combination, Ivacaftor,
Completed
- Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
- Lumacaftor Plus Ivacaftor Combination
- +2 more
-
Birmingham, Alabama
- +89 more
Aug 1, 2015
Cystic Fibrosis Trial (ivacaftor, VX-661, ciprofloxacin)
Completed
- Cystic Fibrosis
- ivacaftor
- +2 more
- (no location specified)
Mar 25, 2014